USD 1.87
(-5.08%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 5.69 Million USD | -48.23% |
2022 | 11 Million USD | -25.67% |
2021 | 14.81 Million USD | 126.94% |
2020 | 6.52 Million USD | 246.76% |
2019 | 1.88 Million USD | 144.73% |
2018 | 769 Thousand USD | 17.76% |
2017 | 653 Thousand USD | -41.38% |
2016 | 1.11 Million USD | 103.23% |
2015 | -34.47 Million USD | -129.14% |
2014 | -15.04 Million USD | -4010.11% |
2013 | -366 Thousand USD | 61.51% |
2012 | -951 Thousand USD | 36.35% |
2011 | -1.49 Million USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2023 FY | 5.69 Million USD | -48.23% |
2023 Q2 | 4.93 Million USD | -15.7% |
2023 Q1 | 5.85 Million USD | -46.78% |
2022 Q1 | 14.27 Million USD | -3.63% |
2022 FY | 11 Million USD | -25.67% |
2022 Q4 | 11 Million USD | -12.52% |
2022 Q3 | 12.58 Million USD | 7.38% |
2022 Q2 | 11.71 Million USD | -17.89% |
2021 Q1 | 9.27 Million USD | 42.05% |
2021 Q4 | 14.81 Million USD | 12.92% |
2021 Q3 | 13.11 Million USD | 49.66% |
2021 FY | 14.81 Million USD | 126.94% |
2021 Q2 | 8.76 Million USD | -5.47% |
2020 Q3 | 5.1 Million USD | 7.37% |
2020 Q4 | 6.52 Million USD | 27.96% |
2020 Q1 | 2.76 Million USD | 47.02% |
2020 FY | 6.52 Million USD | 246.76% |
2020 Q2 | 4.75 Million USD | 71.67% |
2019 Q2 | 1.82 Million USD | 41.77% |
2019 Q3 | 1.96 Million USD | 7.39% |
2019 Q4 | 1.88 Million USD | -4.03% |
2019 FY | 1.88 Million USD | 144.73% |
2019 Q1 | 1.28 Million USD | 67.49% |
2018 FY | 769 Thousand USD | 17.76% |
2018 Q4 | 769 Thousand USD | 63.97% |
2018 Q3 | 469 Thousand USD | -32.03% |
2018 Q2 | 690 Thousand USD | 23.21% |
2018 Q1 | 560 Thousand USD | -14.24% |
2017 Q1 | - USD | -100.0% |
2017 FY | 653 Thousand USD | -41.38% |
2017 Q4 | 653 Thousand USD | 195.48% |
2017 Q3 | 221 Thousand USD | -63.77% |
2017 Q2 | 610 Thousand USD | 0.0% |
2016 Q1 | - USD | 100.0% |
2016 FY | 1.11 Million USD | 103.23% |
2016 Q4 | 1.11 Million USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2015 FY | -34.47 Million USD | -129.14% |
2015 Q4 | -34.47 Million USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 100.0% |
2014 Q1 | - USD | 100.0% |
2014 FY | -15.04 Million USD | -4010.11% |
2014 Q4 | -15.04 Million USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2013 Q4 | -366 Thousand USD | 0.0% |
2013 FY | -366 Thousand USD | 61.51% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 100.0% |
2013 Q3 | - USD | 0.0% |
2012 FY | -951 Thousand USD | 36.35% |
2012 Q3 | - USD | 0.0% |
2012 Q4 | -951 Thousand USD | 0.0% |
2011 Q4 | -1.49 Million USD | 0.0% |
2011 FY | -1.49 Million USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Cosmos Health Inc. | 4.78 Million USD | -19.001% |
Safety Shot Inc | 1.86 Million USD | -204.819% |
Bright Green Corporation | - USD | -Infinity% |
Embecta Corp. | 152.1 Million USD | 96.253% |
ANI Pharmaceuticals, Inc. | 111.19 Million USD | 94.875% |
Aquestive Therapeutics, Inc. | 6.76 Million USD | 15.807% |
Collegium Pharmaceutical, Inc. | 32.33 Million USD | 82.373% |
Dynavax Technologies Corporation | 53.29 Million USD | 89.306% |
Esperion Therapeutics, Inc. | 65.62 Million USD | 91.315% |
Intra-Cellular Therapies, Inc. | 11.64 Million USD | 51.069% |
Pacira BioSciences, Inc. | 104.35 Million USD | 94.539% |
PainReform Ltd. | - USD | -Infinity% |
Sunshine Biopharma, Inc. | 5.73 Million USD | 0.623% |
Sunshine Biopharma, Inc. | 5.73 Million USD | 0.623% |
SCYNEXIS, Inc. | - USD | -Infinity% |
China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -603.795% |
Journey Medical Corporation | 10.2 Million USD | 44.16% |
Alpha Teknova, Inc. | 11.59 Million USD | 50.845% |
Procaps Group, S.A. | 96.83 Million USD | 94.115% |
Theratechnologies Inc. | 6.06 Million USD | 6.05% |
Harrow Health, Inc. | 10.86 Million USD | 47.557% |
Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -109.6% |
Biofrontera Inc. | 10.9 Million USD | 47.754% |
DURECT Corporation | 2.21 Million USD | -156.829% |
Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 92.638% |
Cronos Group Inc. | 30.33 Million USD | 81.215% |
OptiNose, Inc. | 8.05 Million USD | 29.222% |
Ironwood Pharmaceuticals, Inc. | 1.00 USD | -569903200.0% |
Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
Organogenesis Holdings Inc. | 28.25 Million USD | 79.829% |
Guardion Health Sciences, Inc. | 2.67 Million USD | -112.88% |
Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -23.64% |
Radius Health, Inc. | 278.64 Million USD | 97.955% |
Universe Pharmaceuticals INC | 3.34 Million USD | -70.463% |
ProPhase Labs, Inc. | 3.84 Million USD | -48.374% |
Phibro Animal Health Corporation | 265.91 Million USD | 97.857% |
Procaps Group S.A. | 96.83 Million USD | 94.115% |
Alvotech | 74.43 Million USD | 92.343% |
TherapeuticsMD, Inc. | - USD | -Infinity% |
Viatris Inc. | 3.46 Billion USD | 99.836% |
Rockwell Medical, Inc. | 5.87 Million USD | 2.929% |
Aytu BioPharma, Inc. | 12.63 Million USD | 54.888% |
SIGA Technologies, Inc. | 64.21 Million USD | 91.126% |
Tilray Brands, Inc. | 252.08 Million USD | 97.739% |
Lifecore Biomedical, Inc. | 39.97 Million USD | 85.745% |
Shineco, Inc. | 1.58 Million USD | -258.763% |
PetIQ, Inc. | 159.3 Million USD | 96.423% |
Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 3830.271% |
Incannex Healthcare Limited | -10.01 Million USD | 156.905% |
Neurocrine Biosciences, Inc. | 38.3 Million USD | 85.12% |
Alimera Sciences, Inc. | 1.87 Million USD | -203.301% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Assertio Holdings, Inc. | 37.68 Million USD | 84.878% |
Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
Petros Pharmaceuticals, Inc. | 1.61 Million USD | -253.891% |
Clever Leaves Holdings Inc. | 4.48 Million USD | -27.125% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -2140.609% |
Avadel Pharmaceuticals plc | 10.38 Million USD | 45.096% |
Hempacco Co., Inc. | 2.54 Million USD | -124.139% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 74.43 Million USD | 92.343% |
Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 88.076% |
Lantheus Holdings, Inc. | 64.02 Million USD | 91.099% |
Currenc Group, Inc. | 732.91 Thousand USD | -677.589% |
Kamada Ltd. | 87.74 Million USD | 93.505% |
Indivior PLC | 141.79 Million USD | 95.981% |
Evoke Pharma, Inc. | 481.84 Thousand USD | -1082.765% |
Flora Growth Corp. | 8.5 Million USD | 33.016% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -2140.609% |
Evolus, Inc. | 10.99 Million USD | 48.181% |
HUTCHMED (China) Limited | 50.25 Million USD | 88.66% |
Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 94.615% |
Akanda Corp. | 1.28 Million USD | -342.852% |